Physician profile
Samy M El-Halawani
NPI 1477505121
$247,876.89
in general payments reported to CMS, 2019-2025
10 companies · $47K in 2025
The $47K reported for 2025 was more than what 98% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $6,351 · 2021: $20K · 2022: $39K · 2023: $46K · 2024: $56K · 2025: $47K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $120K · Travel and Lodging: $18K · Consulting Fee: $7,800 · Food and Beverage: $2,838 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $120,156.93 |
| Travel and Lodging | $18,497.37 |
| Consulting Fee | $7,800.00 |
| Food and Beverage | $2,838.47 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $65,266.01 | 2022-2025 | Uptravi, Opsumit |
| United Therapeutics Corporation | $63,688.34 | 2022-2025 | Tyvaso, Remodulin, Orenitram |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53,378.62 | 2020-2025 | Ofev |
| Insmed, INC. | $32,529.14 | 2019-2023 | Arikayce |
| Gilead Sciences, INC. | $21,613.64 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $10,250.33 | 2024-2025 | Winrevair |
| Inari Medical, INC. | $1,095.13 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Philips North America LLC | $25.24 | 2022-2023 | |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Itamar Medical INC | $10.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samy El-Halawani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.